Terilyn J. Monroe net worth and biography

Terilyn Monroe Biography and Net Worth

Insider of Guardant Health

Terilyn Juarez Monroe is the Chief People Officer at Guardant Health, where she is responsible for the end to end talent strategy and global People team. Prior to Guardant Health, Monroe held chief people officer roles at Varian, Acxiom (now called LiveRamp) and privately held Bonterra. Additionally, she held various HR and communication leadership roles at Intuit, Nortel Networks and Bay Networks. She has been recognized with the 2025 CHRO of the Year - Lifetime Achievement Award by HRO Today. Monroe is Directorship Certified by the National Association of Corporate Directors, an American Leadership Forum Senior Fellow, and a board member of the non-profit CASSY. Monroe has a Bachelor of Science in Public Relations, Business Minor from San José State University.

What is Terilyn J. Monroe's net worth?: The estimated net worth of Terilyn J. Monroe is at least $2.27 million as of December 1st, 2025. Ms. Monroe owns 20,920 shares of Guardant Health stock worth more than $2,270,238 as of December 5th. This net worth estimate does not reflect any other investments that Ms. Monroe may own. Learn More about Terilyn J. Monroe's net worth.
How old is Terilyn J. Monroe?: Ms. Monroe is currently 57 years old. There are 6 older executives and no younger executives at Guardant Health. The oldest executive at Guardant Health is Mr. Kumud Kalia, Chief Information Officer, who is 58 years old. Learn More on Terilyn J. Monroe's age.
How do I contact Terilyn J. Monroe?: The corporate mailing address for Ms. Monroe and other Guardant Health executives is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Guardant Health can also be reached via phone at (855) 698-8887 and via email at [email protected]. Learn More on Terilyn J. Monroe's contact information.
Has Terilyn J. Monroe been buying or selling shares of Guardant Health?: Over the course of the past ninety days, Terilyn J. Monroe has sold $5,846,046.99 in shares of Guardant Health stock. Most recently, Terilyn J. Monroe sold 55,167 shares of the business's stock in a transaction on Monday, December 1st. The shares were sold at an average price of $105.97, for a transaction totalling $5,846,046.99. Following the completion of the sale, the insider now directly owns 20,920 shares of the company's stock, valued at $2,216,892.40. Learn More on Terilyn J. Monroe's trading history.
Who are Guardant Health's active insiders?: Guardant Health's insider roster includes Derek Bertocci (CFO), Ian Clark (Director), Helmy Eltoukhy (CEO), Medina Hidalgo (Director), Meghan Joyce (Director), Kumud Kalia (Insider), Samir Kaul (Director), Stanley Meresman (Director), Amelia Merrill (SVP), Terilyn Monroe (Insider), Myrtle Potter (Director), John Saia (Insider), Amirali Talasaz (COO), and Musa Tariq (Director). Learn More on Guardant Health's active insiders.
Are insiders buying or selling shares of Guardant Health?: During the last year, insiders at the sold shares 33 times. They sold a total of 713,670 shares worth more than $42,038,200.84. The most recent insider tranaction occured on December, 1st when insider Terilyn J Monroe sold 55,167 shares worth more than $5,846,046.99. Insiders at Guardant Health own 6.1% of the company. Learn More about insider trades at Guardant Health.
Information on this page was last updated on 12/1/2025.

Terilyn J. Monroe Insider Trading History at Guardant Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/1/2025	Sell	55,167	$105.97	$5,846,046.99	20,920

Terilyn J. Monroe Buying and Selling Activity at Guardant Health

Guardant Health Company Overview

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Today's Range

Now: $106.88

$107.05

$108.84

50 Day Range

MA: $83.83

$60.03

$111.25

2 Week Range

Now: $106.88

$29.91

$112.43

Volume

86,549 shs

Average Volume

2,455,874 shs

Market Capitalization

$13.47 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58

Terilyn Monroe Biography and Net Worth

What is Terilyn J. Monroe's net worth?

How old is Terilyn J. Monroe?

How do I contact Terilyn J. Monroe?

Has Terilyn J. Monroe been buying or selling shares of Guardant Health?

Who are Guardant Health's active insiders?

Are insiders buying or selling shares of Guardant Health?